TCERG1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	18 studies	27% ± 12%	Explore
B cell	12 studies	21% ± 4%	Explore
astrocyte	12 studies	30% ± 13%	Explore
glutamatergic neuron	11 studies	42% ± 25%	Explore
oligodendrocyte precursor cell	11 studies	34% ± 13%	Explore
CD8-positive, alpha-beta T cell	11 studies	21% ± 5%	Explore
CD4-positive, alpha-beta T cell	10 studies	22% ± 6%	Explore
pericyte	10 studies	24% ± 13%	Explore
fibroblast	10 studies	23% ± 6%	Explore
natural killer cell	10 studies	22% ± 5%	Explore
GABAergic neuron	9 studies	40% ± 22%	Explore
epithelial cell	9 studies	33% ± 17%	Explore
microglial cell	9 studies	27% ± 9%	Explore
naive B cell	9 studies	22% ± 4%	Explore
oligodendrocyte	9 studies	27% ± 10%	Explore
plasmacytoid dendritic cell	8 studies	23% ± 5%	Explore
dendritic cell	8 studies	28% ± 13%	Explore
CD16-negative, CD56-bright natural killer cell, human	7 studies	19% ± 3%	Explore
macrophage	7 studies	32% ± 7%	Explore
adipocyte	7 studies	23% ± 6%	Explore
ciliated cell	7 studies	24% ± 5%	Explore
hematopoietic precursor cell	6 studies	24% ± 8%	Explore
CD16-positive, CD56-dim natural killer cell, human	6 studies	18% ± 4%	Explore
abnormal cell	6 studies	27% ± 11%	Explore
neuron	6 studies	37% ± 9%	Explore
interneuron	6 studies	46% ± 23%	Explore
memory B cell	6 studies	22% ± 4%	Explore
basal cell	6 studies	32% ± 13%	Explore
T cell	6 studies	20% ± 3%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	19% ± 3%	Explore
lymphocyte	5 studies	22% ± 5%	Explore
mucosal invariant T cell	5 studies	19% ± 3%	Explore
precursor B cell	5 studies	28% ± 6%	Explore
pro-B cell	5 studies	27% ± 6%	Explore
myeloid cell	5 studies	23% ± 4%	Explore
myofibroblast cell	5 studies	21% ± 6%	Explore
endothelial cell of lymphatic vessel	5 studies	28% ± 7%	Explore
smooth muscle cell	5 studies	21% ± 2%	Explore
gamma-delta T cell	5 studies	26% ± 14%	Explore
regulatory T cell	5 studies	22% ± 7%	Explore
CD4-positive, alpha-beta memory T cell	5 studies	20% ± 2%	Explore
plasmablast	4 studies	39% ± 15%	Explore
conventional dendritic cell	4 studies	31% ± 14%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	17% ± 1%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	21% ± 4%	Explore
granule cell	4 studies	27% ± 2%	Explore
progenitor cell	4 studies	24% ± 7%	Explore
immature B cell	4 studies	24% ± 5%	Explore
amacrine cell	4 studies	24% ± 9%	Explore
respiratory goblet cell	4 studies	26% ± 5%	Explore
type I pneumocyte	4 studies	19% ± 6%	Explore
goblet cell	4 studies	34% ± 17%	Explore
secretory cell	3 studies	27% ± 7%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	3 studies	23% ± 6%	Explore
non-classical monocyte	3 studies	22% ± 5%	Explore
connective tissue cell	3 studies	20% ± 2%	Explore
GABAergic interneuron	3 studies	31% ± 10%	Explore
retinal ganglion cell	3 studies	27% ± 7%	Explore
plasma cell	3 studies	29% ± 11%	Explore
retina horizontal cell	3 studies	23% ± 6%	Explore
retinal bipolar neuron	3 studies	21% ± 1%	Explore
retinal cone cell	3 studies	23% ± 6%	Explore
vein endothelial cell	3 studies	27% ± 16%	Explore
glycinergic amacrine cell	3 studies	20% ± 4%	Explore
retinal rod cell	3 studies	20% ± 3%	Explore
rod bipolar cell	3 studies	21% ± 8%	Explore
hematopoietic stem cell	3 studies	27% ± 2%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	33% ± 15%	Explore
club cell	3 studies	26% ± 7%	Explore
monocyte	3 studies	23% ± 4%	Explore
type II pneumocyte	3 studies	20% ± 6%	Explore
transit amplifying cell	3 studies	40% ± 22%	Explore
erythroblast	3 studies	35% ± 14%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
brain	16 studies	34% ± 20%	Explore
peripheral blood	6 studies	23% ± 5%	Explore
eye	5 studies	24% ± 10%	Explore
lung	4 studies	25% ± 6%	Explore
adipose	4 studies	19% ± 2%	Explore
bone marrow	3 studies	20% ± 4%	Explore
intestine	3 studies	21% ± 5%	Explore
liver	3 studies	34% ± 12%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	4231.97	578 / 578	100%	20.58	1155 / 1155
ovary	100%	5617.44	180 / 180	100%	18.31	430 / 430
esophagus	100%	4078.54	1444 / 1445	100%	29.91	183 / 183
intestine	100%	4685.37	966 / 966	100%	22.50	526 / 527
stomach	100%	3300.82	359 / 359	100%	22.58	285 / 286
breast	100%	5100.30	459 / 459	100%	23.55	1114 / 1118
bladder	100%	5091.38	21 / 21	100%	22.23	502 / 504
prostate	100%	5293.48	245 / 245	99%	16.23	499 / 502
adrenal gland	100%	3267.56	258 / 258	99%	15.07	227 / 230
uterus	100%	5592.14	170 / 170	99%	26.28	453 / 459
thymus	100%	4635.48	653 / 653	99%	15.89	596 / 605
brain	99%	4197.15	2604 / 2642	100%	23.79	704 / 705
pancreas	100%	2210.32	328 / 328	98%	18.82	175 / 178
skin	100%	5217.18	1809 / 1809	98%	20.43	462 / 472
kidney	100%	2927.91	89 / 89	96%	15.00	867 / 901
liver	100%	1829.46	225 / 226	84%	8.95	342 / 406
adipose	100%	4479.43	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	24.23	29 / 29
muscle	100%	3929.62	803 / 803	0%	0	0 / 0
spleen	100%	5323.45	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	23.96	45 / 45
ureter	0%	0	0 / 0	100%	9.93	1 / 1
blood vessel	100%	3848.12	1333 / 1335	0%	0	0 / 0
heart	98%	2450.24	842 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	80%	10.65	64 / 80
peripheral blood	50%	2580.05	460 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0006397	Biological process	mRNA processing
GO_0034244	Biological process	negative regulation of transcription elongation by RNA polymerase II
GO_0000122	Biological process	negative regulation of transcription by RNA polymerase II
GO_0032968	Biological process	positive regulation of transcription elongation by RNA polymerase II
GO_0008380	Biological process	RNA splicing
GO_0045944	Biological process	positive regulation of transcription by RNA polymerase II
GO_0016607	Cellular component	nuclear speck
GO_0005654	Cellular component	nucleoplasm
GO_0005634	Cellular component	nucleus
GO_0070063	Molecular function	RNA polymerase binding
GO_0003714	Molecular function	transcription corepressor activity
GO_0042802	Molecular function	identical protein binding
GO_0003712	Molecular function	transcription coregulator activity
GO_0061629	Molecular function	RNA polymerase II-specific DNA-binding transcription factor binding
GO_0003711	Molecular function	transcription elongation factor activity
GO_0003723	Molecular function	RNA binding
GO_0044390	Molecular function	ubiquitin-like protein conjugating enzyme binding
GO_0003713	Molecular function	transcription coactivator activity
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	TCERG1
Protein name	Transcription elongation regulator 1 Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150)
Synonyms	hCG_38116 CA150 TAF2S
Description	FUNCTION: Transcription factor that binds RNA polymerase II and inhibits the elongation of transcripts from target promoters. Regulates transcription elongation in a TATA box-dependent manner. Necessary for TAT-dependent activation of the human immunodeficiency virus type 1 (HIV-1) promoter. .
Accessions	ENST00000679501.2 ENST00000394421.7 [O14776-2] G3V220 ENST00000296702.9 [O14776-1] ENST00000707168.1 A0A7P0T8N8 A0AA34QVU1 ENST00000707167.1 O14776 ENST00000549332.1 A0AA34QVF9

TCERG1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review